scholarly journals Spa therapy interventions for post respiratory rehabilitation in COVID-19 subjects: does the review of recent evidence suggest a role?

2021 ◽  
Author(s):  
Maria Chiara Maccarone ◽  
Stefano Masiero
Keyword(s):  
Pulmonary Rehabilitation ◽  
Spa Therapy ◽  
Respiratory Impairment ◽  
Randomized Controlled ◽  
Number Of Patients ◽  
Therapy Interventions ◽  
Discharge From Hospital ◽  
Respiratory Outcomes ◽  
Respiratory Rehabilitation

Abstract Pulmonary rehabilitation is essential in post-COVID subjects reporting respiratory impairment after the discharge from hospital. Because the number of patients with respiratory outcomes is high and there are few facilities available, we wonder if spa setting could represent a valid out-of-hospital alternative. We aim to explore recent evidence related to respiratory rehabilitation in the spa environment to understand if it can represent an appropriate setting for respiratory rehabilitation interventions in post-COVID subjects. Studies were found by screening PubMed, MIDLINE and Google Scholar databases from 2011 up to February 2021. Studies were eligible if they were reviews, randomized controlled trials (RCTs) or clinical trials investigating respiratory interventions in the spa environment. Recent evidence has shown that inhalations and mineral-rich water immersions are effective in fighting and preventing multiple chronic respiratory tract diseases.Therefore, these treatments could also be applied to post-COVID patients with medium- long term respiratory outcomes.

scholarly journals Spa therapy interventions for post respiratory rehabilitation in COVID-19 subjects: does the review of recent evidence suggest a role?

2021 ◽  
Author(s):  
Maria Chiara Maccarone ◽  
Stefano Masiero
Keyword(s):  
Pulmonary Rehabilitation ◽  
Spa Therapy ◽  
Controlled Trials ◽  
Respiratory Impairment ◽  
Randomized Controlled ◽  
Number Of Patients ◽  
Therapy Interventions ◽  
Respiratory Outcomes ◽  
Respiratory Rehabilitation

AbstractPulmonary rehabilitation is essential in post-COVID subjects, reporting respiratory impairment after the discharge from the hospital. Because the number of patients with respiratory outcomes is high and there are few facilities available, we wonder if a spa setting could represent a valid out-of-hospital alternative. We aim to explore recent evidence related to respiratory rehabilitation in the spa environment to understand if it can represent an appropriate setting for respiratory rehabilitation interventions in post-COVID subjects. Studies were found by screening PubMed, MEDLINE, and Google Scholar databases from 2011 up to February 2021. Studies were eligible if they were reviews, randomized controlled trials (RCTs), or clinical trials, investigating respiratory interventions in the spa environment. Recent evidence has shown that inhalations and mineral-rich water immersions are effective in fighting and preventing multiple chronic respiratory tract diseases. Therefore, these treatments could also be applied to post-COVID patients with medium long-term respiratory outcomes.

scholarly journals Long-term Exercise After Pulmonary Rehabilitation (LEAP): Design and rationale of a randomized controlled trial of Tai Chi

2015 ◽  
Vol 45 ◽  
pp. 458-467 ◽  
Author(s):  
Marilyn L. Moy ◽  
Peter M. Wayne ◽  
Daniel Litrownik ◽  
Douglas Beach ◽  
Elizabeth S. Klings ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Pulmonary Rehabilitation ◽  
Tai Chi ◽  
Controlled Trial ◽  
Randomized Controlled

scholarly journals Long-Term Benefits of Adding a Pedometer to Pulmonary Rehabilitation for COPD: The Randomized Controlled STAR Trial

2021 ◽  
Vol Volume 16 ◽  
pp. 1977-1988
Author(s):  
Wolfgang Geidl ◽  
Johannes Carl ◽  
Michael Schuler ◽  
Eriselda Mino ◽  
Nicola Lehbert ◽  
...  
Keyword(s):  
Pulmonary Rehabilitation ◽  
Randomized Controlled ◽  
Star Trial

Ixekizumab in the Management of Non-Selected Out Patients with Moderate to Severe Psoriasis -New Data and Personal Clinical Experience

2018 ◽  
Vol 3 (3) ◽  
Keyword(s):  
Clinical Experience ◽  
Personal Experience ◽  
Therapeutic Response ◽  
Systemic Disease ◽  
Severe Psoriasis ◽  
Adequate Treatment ◽  
Scalp Psoriasis ◽  
Number Of Patients ◽  
Genital Psoriasis

Introduction: Too many patients with moderate to severe psoriasis do not receive adequate treatment. This means a vast undersupply in the treatment of patients with psoriasis. Only biologics fulfill the whole range of the treatment of psoriasis – psoriasis does not affect only skin but the whole organism: It is a systemic disease! Between the biologics are evident differences concerning the effect. Discussion: Based on broad personal experience in the management of patients with moderate to severe psoriasis new data from clinical studies with ixekizumab are examined. This contains new data on long-term-efficacy of ixekizumab, effectiveness in special localizations (scalp psoriasis, nail psoriasis, palmoplantar psoriasis, genital psoriasis) as well as safely data and experience on patients switched to ixekizumab from other biologics. Personal clinical experience is based on >300 non-selected outpatients with moderate to severe psoriasis, >250 patients on biological therapies, > 50 patients with ixekizumab. Conclusions: Focusing on a relevant number of patients switched from secukinumab to ixekizumab due to first or secondary loss of efficacy significant differences between both IL-17A-inhibitors mainly in terms of efficacy and speed of therapeutic response are shown. Finally the correlation between PASI-90-/PASI-100 response and significant changes in DLQI are highlighted.

Sign in / Sign up

Export Citation Format

Share Document